Can I track the raw materials?

Yes, we ensure full traceability of raw materials to maintain product integrity.

Where are the main markets for this product?

Our main markets include Europe, Southeast Asia, the Middle East, Africa, and domestic regions.

Mindray 3 Diff Lyse Hematology Reagent for Blood Hematology Analyzer

Name: Mindray 3 Diff Lyse Hematology Reagent for Blood Hematology Analyzer
Brand: Zhejiang Xinke Medical Technology Co., Ltd.
SKU: 2203598565

Zhejiang, ChinaZhejiang Xinke Medical Technology Co., Ltd.

US$1.00

1 Piece

Product profile

Customization

Available

Type

IVD Reagent

OEM

Welcome

Model NO.

JXK-204

Certification

ISO13485

Transport Package

Carton and Pallet

Trademark

xinke

Origin

China

HS Code

3822009000

Production Capacity

5000cartons/Year

Key features

Flexible Customization: OEM service available with flexible customization options for reagents.

Certified Quality: Manufactured under ISO13485 and ISO9001:2015 certified management systems.

Experienced Manufacturer: Established in 2004 with 20 years of export experience and 16 R&D engineers.

Strict Quality Control: 100% inspection of finished products including visual and function checks.

Traceable Materials: Full traceability of raw materials ensures consistent product quality.

Global Reach: Main markets include Europe, Southeast Asia, Middle East, and Africa.

Fast Delivery: Average lead time within 15 workdays for both peak and off-season.

Low MOQ: Minimum order quantity is just 1 piece, suitable for various buyers.

Company profile

Importers and ExportersYears of Export Experience

Zhejiang Xinke Medical Technology Co., Ltd.

Zhejiang, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: OEM Service Available CertifiedCustomization Options: Flexible customization CertifiedExport Year: 20 Years CertifiedNearest Port: Ningbo PortAverage Response Time: ≤2.91h

AI-Powered supplier vetting

SummaryThe supplier operates in the clinical in vitro diagnostic reagent field and reports ten years of ISO9001 and ISO13485 quality-system certification. It offers flexible customization, has OEM experience with well-known brands, possesses self-managed import/export rights, and has exported for 20 years, with exports representing 51%–70% of total sales. Quality inspection procedures are documented and consistently followed, while stated lead times are within 15 working days in both peak and off-season. However, the supplier reports no inventory, overseas warehouse, overseas showroom, overseas agents or branches, offline trade-show participation, ODM service, SDK, recent new-product development, ERP, OA, CRM, SAP, or broader digitalization initiatives. Financial information is inconsistent or insufficiently interpretable in the provided records, so financial credibility cannot be determined.

Supplier typeThe supplier identifies itself as a company in the clinical in vitro diagnostic reagent field and has self-managed import/export rights with 20 years of export experience. This supports classification as an export-capable manufacturer or supplier in the medical in vitro diagnostics sector.

CertificationsThe company states that it has maintained ISO9001 and ISO13485 quality-system certifications for ten years. These explicitly documented certifications support a positive assessment of its quality-system credentials.

R&D capabilityThe supplier reports no new products in the past year, no ODM service, no available SDK, and no current enterprise digitalization or technical-transformation plan. These explicit limitations indicate weak demonstrated innovation capability.

Customization capabilityThe supplier explicitly provides flexible customization through both its R&D and design-service capabilities. This directly supports a positive assessment of customization capability, although ODM service is not offered.

Client casesThe supplier states that it provides OEM services for well-known brands, which is evidence of relevant customer experience. No specific brand names, project details, or verifiable case descriptions are provided, so the evidence is positive but limited.